中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
MeSH:(Proteasome Inhibitors/therapeutic use*)

1.Research Progress of Ubiquitin Proteasome Inhibitors in Acute Myeloid Leukemia.

Fang-Nan XIAO ; Ming-Ying ZHANG ; Yuan ZHOU

Acta Academiae Medicinae Sinicae 2022;44(5):868-875

2.Effects of proteasome inhibitors on leukemias.

Shu-Qing LÜ ; Jian-Min YANG ; Jian-Min WANG

Journal of Experimental Hematology 2007;15(4):896-900

3.Role of proteasome inhibition in sensitized transplant candidates.

Matthew J EVERLY ; Jason J EVERLY ; Paul I TERASAKI

Chinese Medical Journal 2011;124(5):771-774

4.Diagnosis and treatment of multiple myeloma in Hunan Province.

Feiyang LIU ; Qian CHENG ; Kui SONG ; Huan YU ; Junjun LI ; Hui ZHANG ; Guoyu HU ; Ming ZHOU ; Jun WANG ; Zhongqi DING ; Zimian LUO ; Ting PENG ; Liang DING ; Liang ZHAO ; Jing LIU ; Yanjuan HE ; Hongling PENG

Journal of Central South University(Medical Sciences) 2022;47(4):497-504

5.Classification and synthesis of ubiquitin-proteasome inhibitor.

Jing LI ; Da-Yong ZHANG ; Xiao-Ming WU

Acta Pharmaceutica Sinica 2009;44(12):1313-1319

6.Research Progress on Mechanism of Bortezomib Resistance in Multiple Myeloma.

Ya-Ru WANG ; Yan-Ping MA

Journal of Experimental Hematology 2023;31(5):1584-1587

7.The Effect of Bortezomib on Expression of Inflammatory Cytokines and Survival in a Murine Sepsis Model Induced by Cecal Ligation and Puncture.

Sang Hoon HAN ; Jin Seok KIM ; Jun Hee WOO ; Su Jin JEONG ; Jeon Soo SHIN ; Young Soo AHN ; June Myung KIM

Yonsei Medical Journal 2015;56(1):112-123

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO